| 2026-08-16 | Presentation | August 2026 Corporate Presentation |
| 2026-08-12 | Press release | Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update |
| 2026-07-31 | Presentation | August 2026 Corporate Presentation |
| 2026-06-30 | Press release | Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New |
| 2026-06-04 | Presentation | June 2026 Corporate Presentation |
| Press release | Earnings Release |
| 2026-05-12 | Press release | Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update |
| 2026-05-12 | Press release | PDF |
| 2026-04-09 | Press release | Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference |
| Press release | Earnings Release |
| 2026-03-30 | Press release | Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update |
| 2026-02-04 | Press release | Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit |
| 2026-01-29 | Press release | UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resu |
| 2026-01-29 | Press release | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission |
| 2025-12-29 | Press release | Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) |
| 2025-11-25 | Press release | Unicycive Therapeutics to Participate in Upcoming Investor Events in December |
| Press release | Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update |
| Press release | Unicycive Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update |
| Press release | Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update |
| 2025-04-01 | Press release | Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference |
| 2025-03-31 | Press release | Earnings Release |
| 2025-03-31 | Press release | PDF: Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update |
| 2024-11-13 | Press release | Earnings Release |
| 2024-11-13 | Press release | Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update |
| 2024-11-13 | Press release | PDF: Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update |
| 2024-10-16 | Press release | Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024 |
| 2024-10-14 | Press release | Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Societ |
| 2024-10-09 | Press release | Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers |
| 2024-09-24 | Press release | Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on |
| 2024-09-16 | Press release | Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024 |
| 2024-08-14 | Press release | Earnings Release |
| 2024-08-14 | Press release | Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update |
| 2024-08-14 | Press release | PDF: Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update |
| 2024-06-25 | Presentation | Oxylanthanum Carbonate (OLC) UNI-OLC-201 Pivotal Trial Topline Data |
| 2024-05-13 | Press release | Earnings Release |
| 2024-05-13 | Press release | Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update |
| 2024-03-28 | Press release | Earnings Release |
| 2024-03-28 | Press release | Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update |
| 2023-11-29 | Press release | Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023 |
| 2023-11-14 | Press release | Earnings Release |